Advertisement
BBGI vs CURI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBGI is a Hold and CURI is a Hold.
BBGI sees MACD Histogram crosses below signal line
BBGI saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 25, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In 47 of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBGI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for BBGI entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBGI advanced for three days, in 152 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
BBGI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.696) is normal, around the industry mean (3.888). P/E Ratio (3.124) is within average values for comparable stocks, (153.580). Projected Growth (PEG Ratio) (0.170) is also within normal values, averaging (1.298). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (0.158) is also within normal values, averaging (8.232).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. BBGI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBGI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
CURI in -5.08% downward trend, falling for three consecutive days on October 09, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CURI declined for three days, in 260 of 293 cases, the price declined further within the following month. The odds of a continued downward trend are 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CURI moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In 15 of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CURI as a result. In 72 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for CURI turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 31 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
CURI moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
CURI broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where CURI advanced for three days, in 173 of 216 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 116 of 141 cases where CURI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.151) is normal, around the industry mean (3.888). CURI's P/E Ratio (1606.560) is considerably higher than the industry average of (153.580). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.298). CURI has a moderately high Dividend Yield (0.114) as compared to the industry average of (0.036). P/S Ratio (2.156) is also within normal values, averaging (8.232).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. CURI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CURI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
BBGI | CURI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 83 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 39 Fair valued | 45 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 90 | |
PRICE GROWTH RATING 1..100 | 65 | 56 | |
P/E GROWTH RATING 1..100 | 86 | 9 | |
SEASONALITY SCORE 1..100 | 85 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BBGI's Valuation (39) in the Broadcasting industry is in the same range as CURI (45) in the null industry. This means that BBGI’s stock grew similarly to CURI’s over the last 12 months.
BBGI's Profit vs Risk Rating (100) in the Broadcasting industry is in the same range as CURI (100) in the null industry. This means that BBGI’s stock grew similarly to CURI’s over the last 12 months.
CURI's SMR Rating (90) in the null industry is in the same range as BBGI (99) in the Broadcasting industry. This means that CURI’s stock grew similarly to BBGI’s over the last 12 months.
CURI's Price Growth Rating (56) in the null industry is in the same range as BBGI (65) in the Broadcasting industry. This means that CURI’s stock grew similarly to BBGI’s over the last 12 months.
CURI's P/E Growth Rating (9) in the null industry is significantly better than the same rating for BBGI (86) in the Broadcasting industry. This means that CURI’s stock grew significantly faster than BBGI’s over the last 12 months.
| BBGI | CURI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 84% |
| Momentum ODDS (%) | N/A | 2 days ago 86% |
| MACD ODDS (%) | 2 days ago 89% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 86% | 2 days ago 86% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 82% |
| Advances ODDS (%) | 27 days ago 71% | 8 days ago 80% |
| Declines ODDS (%) | 2 days ago 86% | 6 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 82% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BBGI’s FA Score shows that 0 FA rating(s) are green while CURI’s FA Score has 1 green FA rating(s).
- BBGI’s FA Score: 0 green, 5 red.
- CURI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BBGI’s TA Score shows that 4 TA indicator(s) are bullish while CURI’s TA Score has 3 bullish TA indicator(s).
- BBGI’s TA Score: 4 bullish, 3 bearish.
- CURI’s TA Score: 3 bullish, 6 bearish.
Price Growth
BBGI (@Broadcasting) experienced а -16.48% price change this week, while CURI (@Broadcasting) price change was -5.78% for the same time period.
The average weekly price growth across all stocks in the @Broadcasting industry was -6.83%. For the same industry, the average monthly price growth was -21.72%, and the average quarterly price growth was -30.30%.
Reported Earning Dates
BBGI is expected to report earnings on Nov 04, 2026.
CURI is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Broadcasting (-6.83% weekly)Broadcasting industry includes companies that operate facilities broadcasting radio and/or television programs. Sirius XM Holdings, Inc. (which provides satellite radio and online radio services); Fox Corporation (news and sports broadcasting on TV); and CBS Corporation (TV broadcasting) are some of the behemoths of this industry. The burgeoning digital space has been a disruption for the industry, propelling them to up the ante on their own digital presence.
Advertisement
BBGI and
Correlation & Price change
A.I.dvisor tells us that BBGI and SBGI have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBGI and SBGI's prices will move in lockstep.
| Ticker / NAME | Correlation To BBGI | 1D Price Change % | ||
|---|---|---|---|---|
| BBGI | 100% | -10.72% | ||
| SBGI - BBGI | 20% Poorly correlated | +0.64% | ||
| IHRT - BBGI | 16% Poorly correlated | -2.62% | ||
| FUBO - BBGI | 11% Poorly correlated | -6.29% | ||
| UONE - BBGI | 5% Poorly correlated | +4.38% | ||
| NXST - BBGI | 4% Poorly correlated | +0.01% | ||
More | ||||
CURI and
Correlation & Price change
A.I.dvisor tells us that CURI and SSP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CURI and SSP's prices will move in lockstep.
| Ticker / NAME | Correlation To CURI | 1D Price Change % | ||
|---|---|---|---|---|
| CURI | 100% | -1.07% | ||
| SSP - CURI | 22% Poorly correlated | +1.79% | ||
| GTN - CURI | 21% Poorly correlated | +1.58% | ||
| BBGI - CURI | 20% Poorly correlated | -10.72% | ||
| NXST - CURI | 17% Poorly correlated | +0.01% | ||
| SGA - CURI | 13% Poorly correlated | -2.99% | ||
More | ||||